Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Remdesivir

Gilead Raises Sales Outlook To Include COVID-19 Treatment Remdesivir

Gilead's second-quarter sales fell nearly 10% from a year earlier to $5.1 billion, short of the average analyst estimate of $5.3 billion, according to Refinitiv.

Read More

COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir for 'restricted emergency use'

COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir for 'restricted emergency use'

Read More

Mylan announces commercial launch of its Remdesivir under brand name DESREMTM in India

Mylan announces commercial launch of its Remdesivir under brand name DESREMTM in India

Read More

Hyderabad: 8 held for illegally selling COVID-19 drugs

Hyderabad: 8 held for illegally selling COVID-19 drugs

Read More

COVID-19: Indiscriminate use of Remdesivir and Tocilizumab can cause more harm than good, says Health Ministry

COVID-19: Indiscriminate use of Remdesivir and Tocilizumab can cause more harm than good, says Health Ministry

Read More

No shortage of COVID-19 medicine in Goa, every patient treated as VIP: Rane

No shortage of COVID-19 medicine in Goa, every patient treated as VIP: Rane

Read More

Strict action will be taken against black marketeers of Remdesivir: Anil Deshmukh

Strict action will be taken against black marketeers of Remdesivir: Anil Deshmukh

Read More

Gilead Says Remdesivir Reduced Risk Of Death In COVID-19 Patients, More Studies Needed

Gilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity as in the study.

Read More

Gilead To Deliver More Remdesivir To Germany, Europe From The Fall

Remdesivir is currently the only drug granted a conditional marketing authorisation by the EU for its use in COVID-19 patients.

Read More

Cipla Prices Its Generic Remdesivir At $53.34 Per Vial, Below Rivals

Privately held Hetero Labs Ltd's version, Covifor, costs 5,400 rupees per vial while Mylan prices Desrem at 4,800 rupees.

Read More

COVID19: Top drug regulator directs states drug controller to be vigilant to stop black marketing of anti-drug Remdesivir

COVID19: Top drug regulator directs states drug controller to be vigilant to stop black marketing of anti-drug Remdesivir

Read More

Mylan Gets DCGI Nod For Remdesivir In India, To Launch At Rs 4,800 Per Vial

The drug will be launched under the brand name Desrem in India and will be available to patients later this month at about 80 per cent below the price tag for wealthy nations.

Read More

Health ministry revises remdesivir dosage for COVID-19 patients

Health ministry revises remdesivir dosage for COVID-19 patients

Read More

DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted emergency use' on COVID-19 patients

DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted emergency use' on COVID-19 patients

Read More

South Korea Says To Begin Talks To Purchase COVID-19 Drug Remdesivir In August

South Korea has reported a total of 12,850 coronavirus cases as of Tuesday with 282 deaths.

Read More